Synthesis of substituted benzylidinohydrazines and their monoamine oxidase inhibitory and anticonvulsant properties.
D000818:Animals; D000927:Anticonvulsants / Q000138:chemical synthesis / Q000494:pharmacology; D001597:Benzylidene Compounds / Q000138:chemical synthesis / Q000494:pharmacology / Q000633:toxicity; D001921:Brain / Q000201:enzymology; D004357:Drug Synergism; D005260:Female; D006834:Hydrazines / Q000138:chemical synthesis / Q000494:pharmacology / Q000633:toxicity; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000138:chemical synthesis / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000927:Anticonvulsants; D001597:Benzylidene Compounds; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; C010373:benzylidinohydrazine; D010424:Pentobarbital; D010433:Pentylenetetrazole